In conclusion, we targeted SLE and RA patients treated with low-dose tacrolimus and we identified sex differences in the C/D values, especially in women; the C/D values were significantly related to age in patients with CYP3A5*3/*3. This evidence concerns the gene CYP3A5 and rheumatoid arthritis.